|
|
|
|
Alzheimer's Disease Articles |
Alzheimer’s Disease Treatment PhasesStep One - Diagnosis Alzheimer’s disease is not easily detected, and it requires a battery of tests to determine if the illness is indeed Alzheimer’s. It is only after an accurate diagnosis on Alzheimer’s’ disease has been arrived at that the second step Alzheimer’s disease treatment can commence. Step Two - Treatment Because Alzheimer’s disease is progressive, it can only be managed; therefore, the patient, caregiver, and family must know the existing and future issues found in the management of this brain disorder. These following medications for the Alzheimer’s disease treatment are intended for informational purposes. Use the medication only upon the advice and the supervision of a physician. For these medicines will help to control the disease, alleviate the patient’s symptoms, and slow down the disease. Alzheimer’s disease treatment entails the use of different kinds of medicine, which is intended to improve the patients’ ability to sleep, function, to slow down their loss of memories, and to control their behavioral troubles. Physicians and other medical staff who are knowledgeable about Alzheimer’s disease are your best help in forming a medication regimen. Medication to Manage the Body This Alzheimer’s disease treatment focuses on the use of sleep medication and anti-anxiety medication. For Alzheimer patients commonly have the inability to get a full night’s sleep and may even wander from their beds at night. Anxiety, extreme agitation, and restlessness are common symptoms that a patient with Alzheimer’s disease suffers from. Therefore, the dispensation of medication will alleviate these symptoms. Antioxidants There are differing medical opinions on the administration of Vitamin E for patients undergoing Alzheimer’s disease treatment. However if you feel this medication is worth a shot, seek the advice of a trained medical practitioner on this matter. Cholinesterase Inhibitors For patients undergoing Alzheimer’s disease treatment, a gradual loss of memory is expected because disease destroys acetylcholine cells – the cell responsible for carrying messages to the brain. Cholinesterase inhibitors work by blocking the enzyme that destroys the acetylcholine cells, allowing the patient to function better and delay the loss of memory. Memantine Memantine is a drug approved in 2003 by the FDA for use in patients undergoing Alzheimer’s disease treatment and suffering from moderate to severe symptoms. The use of this drug in patients with Alzheimer’s disease is favorable. By allowing the patients the increased ability to complete daily activities, they suffer from less mood swings and behavioral changes. It is important to seek the help of a trained physician, who is a knowledge expert of the disease. 
|
|
|
|
Alzheimer's Disease & Parkinsons - Is There a Connection?
|
legal notices and disclaimers | resources
Copyright © 2006 Alzheimer's Disease Care